Cargando…
Cost-Effective Pharmacologic Therapies to Treat Chronic Hepatitis B: How Far Have We Really Come?
Autor principal: | Holbrook, Michelle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Managed Care Pharmacy
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437581/ https://www.ncbi.nlm.nih.gov/pubmed/18240884 http://dx.doi.org/10.18553/jmcp.2008.14.1.65 |
Ejemplares similares
-
Review of Two Decades of Cholera Diagnostics – How Far Have We Really Come?
por: Dick, Michal H., et al.
Publicado: (2012) -
Sixth Africa malaria day in 2006: how far have we come after the Abuja Declaration?
por: Rugemalila, Joas B, et al.
Publicado: (2006) -
Milestones in Heart Failure: How Far We Have Come and How Far We Have Left to Go
por: Gajjela, Harini, et al.
Publicado: (2021) -
Immunotherapy in myeloma: how far have we come?
por: Franssen, Laurens E., et al.
Publicado: (2019) -
Intravenous iron therapy: how far have we come?
por: Cançado, Rodolfo Delfini, et al.
Publicado: (2011)